Medication non-adherence in women with fibromyalgia

被引:53
|
作者
Sewitch, MJ
Dobkin, PL
Bernatsky, S
Baron, M
Starr, M
Cohen, M
Fitzcharles, MA
机构
[1] McGill Univ, Dept Med, Montreal, PQ, Canada
[2] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada
[3] McGill Univ, Ctr Hlth, Jewish Gen Hosp, Div Rheumatol, Montreal, PQ, Canada
关键词
fibromyalgia; determinants; medication; non-adherence; women;
D O I
10.1093/rheumatology/keh141
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To identify the determinants of medication non-adherence in women with fibromyalgia (FM). Methods. Participants included 10 rheumatologists and 127 women recruited from tertiary care hospitals and the community. Demographic, clinical and psychosocial characteristics and patient-physician discordance were assessed at the baseline visit. Non-adherence was assessed 2 weeks later. Multivariable generalized estimating equations were used to identify determinants of non-adherence to medication. Results. The average age of the women was 50.4 (S.D. 10.5) yr and the mean disability score was 60.3 (16.0) yr. Sixty (47.2%) women were non-adherent to medication; 20 (33.3%) of these were intentionally non-adherent, 24 (40.0%) were unintentionally non-adherent, and the remaining subjects were both. Overall non-adherence was predicted by higher patient-physician discordance. Unintentional non-adherence was predicted by community subjects, not being under a rheumatologist's care, less disease activity, less use of instrumental coping, and higher patient-physician discordance. Intentional non-adherence was predicted by shorter duration under a rheumatologist's care and higher patient-physician discordance. Conclusion. The therapeutic relationship, in addition to clinical and psychosocial characteristics, influenced non-adherence to medication.
引用
收藏
页码:648 / 654
页数:7
相关论文
共 50 条
  • [1] Non-adherence to medication and cardiovascular risk
    Stewart, Ralph A. H.
    Kerr, Andrew
    NEW ZEALAND MEDICAL JOURNAL, 2011, 124 (1343) : 6 - 10
  • [2] Predicting Persistent Medication Non-Adherence
    Berger, Matthew
    Cox, Jill
    Imershein, Sarah
    Jackson, Richard
    DIABETES, 2012, 61 : A176 - A176
  • [3] Medication non-adherence in essential tremor
    Louis, Elan D.
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (02) : 138 - 141
  • [4] Non-adherence to prophylactic medication Reply
    Craig, Heather
    Wright, Brad
    AUSTRALIAN FAMILY PHYSICIAN, 2013, 42 (1-2) : 8 - 8
  • [5] Importance of Early Non-Adherence in Estimations of Medication Adherence
    Raebel, Marsha A.
    Carroll, Nikki M.
    Ellis, Jennifer L.
    Schroeder, Emily B.
    Bayliss, Elizabeth A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S135 - S135
  • [6] Non-adherence to Appointments Is a Strong Predictor of Medication Non-Adherence and Outcomes in Kidney Transplant Recipients
    Salas, M. Posadas
    Pullalarevu, R.
    Kamel, M.
    Chokkalingam, A.
    Browning, R.
    Kadri, B.
    Salazar, M.
    Srinivas, T.
    Taber, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 517 - 517
  • [7] Non-Adherence to Appointments is a Strong Predictor of Medication Non-Adherence and Outcomes in Kidney Transplant Recipients
    Mohamed, Mahmoud
    Soliman, Karim
    Pullalarevu, Raghavesh
    Kamel, Mahmoud
    Srinivas, Titte
    Taber, David
    Salas, Maria Aurora Posadas
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2021, 362 (04): : 381 - 386
  • [8] Identifying risk factors for medication non-adherence
    Oldenquist, G
    Fried, L
    Rubin, G
    Xue, Q
    Carlson, M
    GERONTOLOGIST, 2002, 42 : 142 - 143
  • [9] The costs of healthcare associated with medication non-adherence
    Ho, P. Michael
    Maddox, Thomas M.
    Shetterly, Susan M.
    Rumsfeld, John S.
    Magid, David J.
    CIRCULATION, 2008, 117 (21) : E460 - E460
  • [10] Clusters of non-adherence to medication in neurological patients
    Prell, Tino
    Grosskreutz, Julian
    Mendorf, Sarah
    Franke, Gabriele Helga
    Witte, Otto W.
    Kunze, Albrecht
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2019, 15 (12): : 1419 - 1424